digital ulcers: Clinical Trials

3 trials for digital ulcers, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 terminated. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Terminated 3

Follow digital ulcers: new trials by email Literature Review of digital ulcers trials Research Report on digital ulcers

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Open-Label Study of Oral Treprostinil in Digital Ulcers
treprostinil diethanolamine - Systemic Sclerosis
Phase 2TerminatedUnited Therapeutics1152009-09-012024-06-18
Safety and Efficacy Study of MRE0094 to Treat Large, Single or Multiple, Chronic, Neuropathic, Diabetic Foot Ulcers
MRE0094, Vehicle gel - Foot Ulcer, Diabetic, Diabetes Complications
Phase 2TerminatedPfizer162006-06-012012-06-01
Effect of Different Iloprost Doses on Symptoms in Systemic Sclerosis
iloprost, iloprost low dose, iloprost therapy up to 2 ng/kg x min - Systemic Sclerosis
Phase 2TerminatedCharite University, Berlin, Germany501997-09-012008-02-25

Narrower conditions

Scleroderma, Systemic (2)  ·  Diabetes Complications (1)  ·  Diabetic Foot (1)  ·  Foot Ulcer (1)  ·  Scleroderma, Diffuse (1)  ·  Vascular Diseases (1)

Broader conditions

Skin Diseases (3)  ·  Skin and Connective Tissue Diseases (3)  ·  Cardiovascular Diseases (2)  ·  Connective Tissue Diseases (2)  ·  Diabetes Mellitus (1)  ·  Diabetic Angiopathies (1)  ·  Diabetic Neuropathies (1)  ·  Endocrine System Diseases (1)  ·  Foot Diseases (1)  ·  Leg Ulcer (1)  ·  Skin Ulcer (1)  ·  Vascular Diseases (1)

Interventions

2-(2-(4-chlorophenyl)ethoxy)adenosine (1)  ·  Iloprost (1)  ·  treprostinil (1)

Sponsors

Charite University, Berlin, Germany (1)  ·  Pfizer (1)  ·  United Therapeutics (1)

Countries

United States (2)  ·  Canada (1)  ·  Germany (1)  ·  United Kingdom (1)

Top investigators

Gabriela Riemekasten, MD (1)  ·  James Seibold, MD (1)  ·  Robert L. Rolleri, Pharm.D. (1)

Results publications

PMID 18634152